Recalls & Warnings April 02, 2016 Propell Platinum Contains Undeclared Drugs On March 29, 2016, the FDA warned consumers not to buy or use the weight loss supplement Propell Platinum because it was found to contain undeclared sibutramine and phenolphthalein
A country still grappling with undernutrition is now experiencing a sharp rise in obesity alongside economic growth, owing to carb-heavy diets, a shift toward processed foods, sedentary lifestyles and environmental factors
Selenium supplementation for Hashimotos thyroiditis: summary of a Cochrane systematic review
Rather than engineer a new single molecule, Novo Nordisk paired an existing approved GLP-1 drug (semaglutide 2.4 mg) with a novel long-acting amylin analogue (cagrilintide)
Lorenz Pasion/Rappler.com Keep us aware of suspicious Facebook pages, groups, accounts, websites, articles, or photos in your network by contacting us at [email protected]